AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $380,000 | +25.4% | 46,169 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $303,000 | +17.4% | 46,169 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $258,000 | +18.9% | 46,169 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $217,000 | -23.9% | 46,169 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $285,000 | -6.2% | 46,169 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $304,000 | +3.1% | 46,169 | +14.4% | 0.01% | 0.0% |
| Q1 2021 | $295,000 | +40.5% | 40,350 | +11.0% | 0.01% | +14.3% |
| Q4 2020 | $210,000 | -2.8% | 36,350 | 0.0% | 0.01% | -22.2% |
| Q3 2020 | $216,000 | +15.5% | 36,350 | 0.0% | 0.01% | +12.5% |
| Q2 2020 | $187,000 | – | 36,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
| Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
| NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
| Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
| Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
| EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
| EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
| J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |